Trial Profile
Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions in Newly Diagnosed Type 2 Diabetes Patients in China.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Repaglinide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 26 Aug 2009 Planned end date changed from 1 Oct 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.
- 05 Feb 2009 New trial record